Bharat Biotech has so far provided more than 9 billion vaccine doses worldwide.
highlights
- Bharat Biotech has so far provided more than 9 billion vaccine doses worldwide.
- The vaccine named COVAXIN against the Corona epidemic was prepared by this company.
- Now the giant vaccine manufacturing company is preparing to enter the primary market.
Vaccine manufacturing giant Bharat Biotech International is considering an IPO. According to Bloomberg report, the company can raise around Rs 4,000–5,000 crore through a potential issue. It is being told that the company is currently keeping an eye on the market situation and the right time to approach SEBI has not been decided yet.
The Hyderabad-based company, established in 1996, says it has so far provided more than 9 billion vaccine doses worldwide. Its portfolio includes vaccines for COVID-19 and Hepatitis B as well as products for the treatment of burns and diarrhea.
Here, the beginning of 2026 in India has been a bit slow in terms of new IPOs, whereas before this, record funds were raised for two consecutive years. The stock market remains under pressure due to slowing earnings of companies, global trade uncertainty and fluctuations in foreign investment. The big IPOs being eyed ahead include Jio Platforms, National Stock Exchange and many real estate companies.
Read full article
About Bharat Biotech..
Bharat Biotech is a leading biotechnology company, which is famous worldwide for its Research and Development (R&D) and manufacturing. The objective of the company is to prepare affordable, safe and high quality vaccines and bio-therapeutics, so that people can control diseases in a better way. The company is striving to become a leader in biotech innovation with a special focus on emerging markets.
Bharat Biotech was started in 1996. The foundation of the company was laid by Dr. Krishna M. Ella and Suchitra Ella after returning from America. His objective was to create a company that would focus on the development of new and effective vaccines and bio-therapeutics. At that time, Dr. Ella was involved in research and teaching in America and his plan was to make the company a center of strong intellectual capability. After inception, the company rapidly strengthened its scientific team and played a leading role in developing several important vaccines. Currently, Bharat Biotech has more than 220 patents registered in its name. The company today has a strong presence in both research and manufacturing, developing effective vaccines and treatments for patients globally.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice in any way. ET NOW Swadesh recommends its readers and viewers to consult their financial advisors before taking any money-related decisions. Mutual fund investment is subject to market risks.
related news
end of article
